FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and represents a liquid pharmaceutical composition for relieving at least one symptom of a disease which requires an adrenergic compound representing adrenalin or its physiologically acceptable salt, and at least one antioxidant specified in a group consisting of bisulphite, metabisulphite and a sulphite compound; a molar ratio of the adrenergic compound and at least one antioxidant specified as sulphite ion equivalents is within the range of 1.31-2.20, while pH of the above liquid composition is found within the range of 2.0-5.0.
EFFECT: invention provides higher storage stability with substantially reduced sensitivity to induced light, thermal and oxidative degradation.
16 cl, 3 ex, 9 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| STABILISED COMPOSITION CONTAINING AT LEAST ONE ADRENERGIC COMPOUND | 2010 |
|
RU2527680C2 |
| DETERGENT WITH STABILISED ENZYME SYSTEMS | 2007 |
|
RU2441062C2 |
| ABT-263 CAPSULE | 2010 |
|
RU2550956C2 |
| PHARMACEUTICAL COMPOSITION FOR PARENTERAL INTRODUCTION AND METHOD OF ITS PRODUCTION | 2016 |
|
RU2635759C1 |
| COMPOSITIONS CONTAINING APOMORPHINE AND ORGANIC ACIDS, AND USING THEM | 2013 |
|
RU2688672C2 |
| COMPOSITIONS, INCLUDING PROTEIN AND CATIONIC POLYMER, AND POSSESSING LOWER VISCOSITY | 2009 |
|
RU2523314C2 |
| LIQUID FOR PROCESSING NEAR-WELLBORE ZONE USING SYSTEM AND OXIDANT-BASED LIQUEFACTION METHOD | 2009 |
|
RU2490297C2 |
| STABILISED LIPID PREPARATIVE FORM OF APOPTOSIS PROMOTER | 2010 |
|
RU2530642C2 |
| METHOD OF TREATING PEROXIDE SOLUTIONS | 2011 |
|
RU2565435C2 |
| COMPOSITION FOR TREATING RHINITIS AND RELATED DISEASES AND METHOD FOR PREPARING IT | 2006 |
|
RU2444351C2 |
